Marinosci, Annalisa

Marinosci, Annalisa; Sculier, Delphine; Wandeler, Gilles; Yerly, Sabine; Stoeckle, Marcel; Bernasconi, Enos; Braun, Dominique L; Vernazza, Pietro; Cavassini, Matthias; Buzzi, Marta; Metzner, Karin J; Decosterd, Laurent; Günthard, Huldrych F; Schmid, Patrick; Limacher, Andreas; Branca, Mattia; Calmy, Alexandra (2024). Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy: the SIMPL'HIV open-label, factorial randomised controlled trial. Swiss medical weekly, 154(4), p. 3762. EMH Schweizerischer Ärzteverlag 10.57187/s.3762

Branca, Mattia; Marinosci, Annalisa; Sculier, Delphine; Wandeler, Gilles; Yerly, Sabine; Stoeckle, Marcel; Bernasconi, Enos; Braun, Dominique L.; Neumann, Kathrin; Vernazza, Pietro; Cavassini, Matthias; Buzzi, Marta; Decosterd, Laurent A.; Schmid, Patrick; Limacher, Andreas; Günthard, Huldrych F.; Metzner, Karin J.; Calmy, Alexandra (2022). Role of the HIV-1 Reservoir to Maintain Viral Suppression in a Simplified Strategy for the Long-Term Management of HIV-1 Infection (The SIMPL’HIV Trial). Frontiers in Virology, 2, p. 855437. Frontiers 10.3389/fviro.2022.855437

Courlet, Perrine; Barbieux, Charlotte; Sculier, Delphine; Wandeler, Gilles; Stoeckle, Marcel; Bernasconi, Enos; Braun, Dominique; Vernazza, Pietro; Cavassini, Matthias; Marinosci, Annalisa; Smit, Mikaela; Günthard, Huldrych F; Schmid, Patrick; Limacher, Andreas; Guidi, Monia; Alves Saldanha, Susana; Decosterd, Laurent Arthur; Calmy, Alexandra (2021). Pharmacokinetic parameters and weight change in HIV patients newly switched to dolutegravir-based regimens in SIMPL'HIV clinical trial. British journal of clinical pharmacology, 87(11), pp. 4455-4460. Wiley-Blackwell 10.1111/bcp.14832

Sculier, Delphine; Wandeler, Gilles; Yerly, Sabine; Marinosci, Annalisa; Stoeckle, Marcel; Bernasconi, Enos; Braun, Dominique L; Vernazza, Pietro; Cavassini, Matthias; Buzzi, Marta; Metzner, Karin J; Decosterd, Laurent A; Günthard, Huldrych F; Schmid, Patrick; Limacher, Andreas; Egger, Matthias; Calmy, Alexandra (2020). Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial. PLoS medicine, 17(11), e1003421. Public Library of Science 10.1371/journal.pmed.1003421

Sculier, Delphine; Wandeler, Gilles; Yerly, Sabine; Marinosci, Annalisa; Stoeckle, Marcel; Bernasconi, Enos; Braun, Dominique L; Vernazza, Pietro; Cavassini, Matthias; Buzzi, Marta; Metzner, Karin J; Decosterd, Laurent; Günthard, Huldrych F; Schmid, Patrick; Limacher, Andreas; Egger, Matthias; Calmy, Alexandra; Swiss HIV, Cohort Study (2020). Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL-HIV trial [Dataset]. University of Bern